Posts Tagged ‘Inovio’
Inovio Pharmaceuticals first quarter 2010 financial results
May 19th, 2010 | 
Author: Inovio Pharmaceuticals Reports First Quarter 2010 Financial Results
BLUE BELL, Pa.—-Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2010.
Read more on Business Wire via Yahoo! Finance
Posted in Uncategorized | 
Tags: 2010, Financial, First, Inovio, Pharmaceuticals, Quarter, Results | 
No Comments »
Inovio Biomedical total revenues increased by $ 2. 6M for the quarter ended December 31, 2009
Inovio Biomedical’s total revenue increased to $2.6M for quarter ended December 31, 2009
Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.
Read more on News-Medical-Net
Posted in Uncategorized |
Tags: 2009, Biomedical, December, ended, Increased, Inovio, Quarter, Revenues, Total |
No Comments »
Reports of the DNA vaccine company Inovio Biomedical fourth quarter year ended 2009 financial results
DNA Vaccine Company Inovio Biomedical Reports Fourth Quarter and Year-Ended 2009 Financial Results
SAN DIEGO—-Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.
Read more on Business Wire via Yahoo! Finance
Inovio Biomedical’s total revenue increased to $2. 6M for quarter ended December 31, 2009
Inovio Biomedical’s total revenue increased to $2.6M for quarter ended December 31, 2009
Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.
Read more on News-Medical-Net
Posted in Uncategorized |
Tags: 2009, Biomedical's, December, ended, Increased, Inovio, Quarter, Revenue, Total |
No Comments »
DNA Vaccine Company Inovio Biomedical Reports Fourth Quarter and Year-Ended 2009 Financial Results
DNA Vaccine Company Inovio Biomedical Reports Fourth Quarter and Year-Ended 2009 Financial Results
SAN DIEGO—-Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.
Read more on Business Wire via Yahoo! Finance
Inovio Biomedical H5N1 avian influenza DNA vaccine receives approval from Korea’s first clinical trials of
Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
SAN DIEGO—-Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine targeting H5N1 avian influenza.
Read more on Business Wire via Yahoo! Finance
Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
SAN DIEGO—-Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine targeting H5N1 avian influenza.
Read more on Business Wire via Yahoo! Finance
